| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |




From the Departments of Medical Biochemistry* and Experimental Hepatology,
Academic Medical Center, University of Amsterdam, Amsterdam; and the Division of Biopharmaceutics,
Leiden/Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands
| Abstract |
|---|
|
|
|---|
5 dyne/cm2, whereas cyclic stretch had no effect. Prolonged LKLF induction in the absence of flow changed the expression of angiotensin-converting enzyme, endothelin-1, adrenomedullin, and endothelial nitric oxide synthase to levels similar to those observed under prolonged flow. LKLF repression by siRNA suppressed the flow response of endothelin-1, adrenomedullin, and endothelial nitric oxide synthase (P < 0.05). Thus, we demonstrate that endothelial LKLF is regulated by flow in vivo and is a transcriptional regulator of several endothelial genes that control vascular tone in response to flow.
repressed LKLF expression in HUVECs, making LKLF a potential marker for the resting, nonactivated state of the endothelial cell. The inverse regulation of LKLF by shear stress and cytokines was later confirmed by others and LKLF was shown to inhibit the induction of cell adhesion molecules by cytokines.9
These findings suggest that the combination of shear stress magnitude and inflammation can be the prime modulator of endothelial LKLF expression in vivo. Endothelial cell gene expression in vivo, however, is under the control of a complex combination of biomechanical, humoral, and various other biological stimuli. This necessitates isolation of these distinct stimuli in dedicated animal models to resolve the prime source of the regulation of the expression of single genes, such as LKLF, in vivo. One of the major, well-studied effects of shear stress on endothelial physiology is its ability to control vascular tone by regulating the transcription of genes that encode proteins with potent vasodilatory or vasoconstrictive properties.10,11 Well-known examples are the shear-repressed endothelin,12 angiotensin-converting enzyme (ACE),13 and adrenomedullin,14 and the shear-induced endothelial nitric oxide synthase (eNOS).11 It was recently demonstrated that LKLF potently induces functional eNOS expression by directly binding its promoter.9 In general, relatively little is known about the signaling pathways used by shear stress to regulate the transcription of these genes, and whether there is a common denominator in these routes and/or transcription factors that mediate their highly endothelial-specific response to flow.
To date, expression of LKLF has been demonstrated in a limited number of cell types, ie, endothelial cells,6,15 naive T cells,16 and preadipocytes.17 High LKLF expression that is observed in naive T cells and preadipocytes is rapidly lost during cell activation/differentiation, thereby presenting LKLF as a marker for cell quiescence or a specific stage of cell differentiation.16,17 Gene-knockout studies in mice have revealed that the expression of LKLF in the endothelium is essential for vasculogenesis in embryonic mice, which elaborated into the concept that downstream products of endothelial LKLF would have a critical role in stabilization of the (new) vessel wall.15,18
To gain more insight into the potential flow-mediated spatial expression of LKLF in endothelial cells, we have studied its detailed in vitro biomechanical regulation and in vivo expression in various human vascular tissues. Using a mouse model in which endothelial shear stress can be locally increased,19 the moderate basal expression of endothelial LKLF was shown to be elevated by shear stress in vivo. Overexpression and knockdown of LKLF in HUVECs revealed that the flow-responsive genes that are involved in the regulation of vascular tone are under transcriptional control of LKLF.
| Materials and Methods |
|---|
|
|
|---|
HUVECs were isolated, cultured, and exposed to shear stress in a parallel plate-type flow chamber as described.6,20
The pulsatile flow of a peristaltic pump (Masterflex 7524-05 pump drive with a 7518-10 pump head; Cole-Parmer, Instrument Co., Chicago, IL) was dampened by placing two three-way taps with windkessels (
80 ml of air) followed by a resistance cannula between the pump and flow cell. For the unidirectional pulsatile flow experiments, an independent 1.2-Hz flow-pulse with an amplitude of 5.7 dyne/cm2 was generated on top of this controllable steady flow (2 to 30 dyne/cm2) by placing a CellMax Quad positive displacement pump (Cellco, Germantown, MD) between the damper assembly and flow cell. For all pump settings, the steady and pulsatile flow patterns were recorded and used to calculate the mean, minimal, and maximal shear stress.6
For the cell-stretch experiments, second-passage HUVEC cultures were grown to confluency on fibronectin-coated BioFlex collagen I plates (Flexcell Inc., Hillsborough, NC). Uniaxial cyclic strain of either 5% or 15% was applied for various time intervals, using a FX-3000 Flexercell Strain Unit (Flexcell) at a cycle frequency of 1 and 0.3 Hz, respectively.
Vascular Tissues and Immunohistochemistry
Human vascular tissue specimens were collected from multiorgan donors after obtaining informed consent (approved by the Academic Medical Center Medical Ethical Committee). For immunohistochemistry and in situ hybridization, vascular tissues were handled and pretreated as described.6 Murine carotid arteries were stained immunohistochemically with antibodies directed against HAM-56 (dilution, 1:50), von Willebrand Factor (vWF) (rabbit anti-human; dilution, 1:250), proliferating cell nuclear antigen (PCNA) (monoclonal mouse anti-human; dilution, 1:100), AIA-31240 (rabbit anti-mouse; dilution, 1:5000), Ly-6G (dilution, 1:500). Secondary antibodies were biotin-labeled rat anti-mouse for PCNA (dilution, 1:400) and goat anti-rabbit for vWF and AIA (dilution, 1:200), which were detected using the StreptABComplex/HRP kit (DakoCytomation, Glostrup, Denmark).
Murine Carotid Artery Collar Model
Carotid artery collar experiments were performed as described.19 For in situ hybridization, male Apo E/ mice of 20 weeks of age were fed a semisynthetic Western-type diet. After 2 weeks, constrictive collars (diameter, 0.3 mm; length, 2 mm) were placed around both carotid arteries. Sham-operated mice were handled and operated identically, but no collar was placed. After continuing feeding the mice a Western-type diet for 2, 5, or 9 days, the carotid arteries were excised, fixed at 4°C for 24 hours in 4% (v/v) paraformaldehyde in phosphate-buffered saline, embedded in paraffin, and sectioned at 20 µm for in situ hybridization. Female wild-type C57BL/6 mice (normal diet) and male ApoE/ mice (Western-type diet) of 8 weeks were used for laser microbeam microdissection (LMM). Collars were placed for a 4-day period, after which the carotid arteries were perfusion-fixed with methacarn (methanol-chloroform-glacial acetic acid at a 6:3:1 ratio), embedded in paraffin, and sectioned at 10 µm for LMM.
LMM
Murine carotid artery sections were mounted onto slides for membrane-based microdissection (Leica Microsystems, Wetzlar, Germany) and subsequently deparaffinized in xylene, followed by washing in absolute ethanol. No staining was performed on these sections to ensure an optimal yield of RNA. Using LMM (P.A.L.M. Microlaser Technologies AG, Bernried, Germany), the endothelium/media was circumferentially excised from 18 proximal and 18 in-collar sections each from the same carotid arteries. Microdissected tissues were collected and stored at 80°C in proteinase K digestion buffer (Ambion, Austin, TX) until further processing. Total RNA was isolated and DNase I treated, using the paraffin block RNA isolation kit (Ambion).
Semiquantitative Real-Time Reverse Transcriptase (RT)-Polymerase Chain Reaction (PCR)
Real-time RT-PCR was performed on total RNA isolated using the Absolutely RNA RT-PCR miniprep kit (Stratagene, La Jolla, CA) as described.6 Gene-specific primers for human and mouse LKLF, hypoxanthine phosphoribosyltransferase (HPRT), endothelin-1, adrenomedullin, ACE, eNOS, and CD31 were designed using Primer3 (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi).21 After correction for HPRT, the human LKLF mRNA levels were expressed as ratios compared to the control cultures.
Nonradioactive mRNA in Situ Hybridization
The in situ hybridization procedure was performed essentially as described.6,22 Riboprobes were derived from the following cDNA fragments: 460-bp BstNI-BstNI fragment of the human LKLF cDNA (GenBank: H28611), a 192-bp fragment of human vWF cDNA 8239 to 8442 bp (GenBank: X04385), 400-bp SalI-PacI fragment (complete 3' untranslated region) of mouse LKLF cDNA (GenBank: AA184928), and a 200-bp fragment of mouse vWF cDNA (GenBank: W20754). All cDNA clones were obtained from the UK Human Genome Mapping Project Resource Centre (Cambridge, UK) as IMAGE-consortium cDNA clones.23 Nuclear counterstaining was performed with nuclear fast red (Sigma, St. Louis, MO). Sections were examined using a Zeiss Axiophot microscope (Carl Zeiss, Jena, Germany) and photographed using a Sony DXC-950P digital camera (Sony Corp., Tokyo, Japan) operated with the Leica QWin software (Leica Imaging Systems Ltd., Cambridge, UK). Linear color corrections to the photomicrographs were made using Adobe Photoshop version 5.0 (Adobe Systems Inc., San Jose, CA).
Lentiviral LKLF Overexpression
The entire human LKLF open reading frame was obtained by RT-PCR, cloned behind the human phosphoglycerate kinase (PGK) promoter of the pRRL-cPPT-PGK-MCS-PRE-SIN vector, and verified by sequencing. Lentiviruses were generated in HEK293T cells as described24,25
and virus-containing supernatants were titrated on HUVECs to determine the titers needed to transduce >95% of the cells. The otherwise identical vector, but without KLF2 cDNA, was used to generate mock viruses for control transductions. First passage HUVEC cultures were transduced at
50% confluency for 24 hours and grown to confluency in passage 2 within the next 7 days. KLF2 overexpression was confirmed by real-time RT-PCR, Western blotting, and fluorescence immunohistochemistry using antisera against two separate synthetic peptides of human LKLF, raised in rabbits by the Eurogentec Double-X program (Eurogentec, Seraing, Belgium).
RNA Interference
A stable knockdown of the KLF2 mRNA was achieved by lentiviral delivery of an expression cassette encoding an siRNA directed against the target sequence AAGACCTACACCAAGAGTTCG. This sequence is unique to KLF2, as determined by the Whitehead Institute (Cambridge, MA) siRNA selection program.26 The siRNA expression cassette was obtained by PCR amplification of the RNA polymerase III H1 promoter from the pSUPER vector,27 using the forward T3 primer and a reverse primer 5'-CTGTCTAGACAAAAAGACCTACACCAAGAGTTCGTCT-CTTGAACGAACTCTTGGTGTAGGTCGGGGATCTGTG-GTCTCATACA-3'. The reverse primer incorporates a 19-bp hairpin DNA sequence preceded by an XbaI restriction site. The PCR product was cloned into the pGEM-T easy vector (Promega, Madison, WI), digested with XbaI and SpeI restriction enzymes, and ligated into an NheI site of the lentiviral vector LV-CMV-GFP(dU3/NheI) (kindly provided by Dr. N.A. Kootstra, Sanquin Research at CLB, Amsterdam, The Netherlands).24,25,28 Viral constructs were packaged and transduced into HUVECs as described in the previous section. The otherwise identical lentiviral vector lacking the siRNA expression cassette was used as a control. First passage primary HUVEC cultures were transduced with the lentiviral KLF2 siRNA and cultured for an additional 2 days before seeding into the artificial capillaries, followed by a 4-day flow exposure as described.6 Effective KLF2 silencing under prolonged flow was confirmed by real-time RT-PCR.
Statistical Analysis
Expression data are given as mean ± SEM for the indicated number of experiments. The unpaired Students t-test was used to calculate the statistical significance of the expression ratios versus control cultures. P values less than 0.05 were considered statistically significant.
| Results |
|---|
|
|
|---|
Because a detailed description of the expression of LKLF in the human vasculature is still lacking, we first examined the expression of LKLF in human umbilical vessels by performing in situ hybridization on cross sections of a human umbilical cord. High levels of LKLF mRNA were observed in the endothelium of the umbilical arteries and vein (Figure 1, A and B)
. The qualitative spatial expression of LKLF in the vascular tree was further investigated by performing in situ hybridization on adult human vascular tissue specimens taken from three different positions in the aorta (aortic arch, abdominal aorta, and aorta bifurcation/iliac arteries) of donors of various ages (13 months to 76 years). Specimens with an intact, vWF-positive endothelium, as evaluated by in situ hybridization, were selected to study the expression of LKLF (Table 1)
. Moderate to high endothelial LKLF hybridization signals were found in all tested sections from donors of all ages (Figure 1; C to H)
. The LKLF mRNA was never detected in the vascular smooth muscle cells (SMCs). High endothelial expression was observed particularly in the aorta of a 13-month-old donor (Figure 1G)
. In some specimens, a LKLF hybridization signal was observed in medial and/or neointimal cells (eg, Figure 1C
), possibly originating from LKLF-expressing infiltrated T cells16
or transdifferentiated endothelial cells.29
|
|
Our previous in vitro studies demonstrated that LKLF is exclusively induced in HUVECs that are exposed to laminar flow, ie, high-shear stress.6
Sudden contrasting differences in endothelial shear stress levels can be observed in vivo near bifurcations, particularly those of the aorta.1,30,31
Thus, from the preselected specimens described in the previous paragraph, the following selection was made: the abdominal aorta bifurcation, the common iliac artery, and the branch of the common carotid artery from the aortic arch. In the aortic arch of a 13-year-old donor, at the geometrically regular sites where laminar flow is generally observed, moderate to high endothelial LKLF expression levels were observed (Figure 2; A to C)
. In contrast, considerably lower amounts of endothelial LKLF mRNA were detected on the shoulder of the vessel wall, separating the aorta and carotid artery (Figure 2D)
.
|
|
There is limited access to human vascular tissues, tissue quality is variable, and observed differences in LKLF expression at bifurcations can only be indirectly related to predicted local flow variations. Therefore, we have used a well-defined mouse model, in which partly constrictive collars are placed around both carotid arteries, to locally increase endothelial shear stress in vivo (see Figure 5A
).19
The fold increase in endothelial shear stress is proportional to the fold decrease in lumen diameter, which is caused by placement of the collar, raised to the third power assuming constant flow, ie, an
50% decreased lumen diameter will lead to an approximately eightfold increase in shear stress. We performed LMM and real-time RT-PCR to accurately assess the effect of flow on the expression of LKLF in the endothelium of the murine carotid arteries. Carotid arteries of three wild-type C57BL/6 mice and three ApoE/ mice received a partly constrictive collar for 4 days, after which they were microdissected along the outer elastic laminae to ensure the isolation of the complete and intact endothelial cell layer (Figure 4, A and B)
. The LKLF mRNA present in these isolates is exclusively of endothelial origin, because no LKLF-expressing cells were detectable by in situ hybridization and RT-PCR in the media. The relative LKLF mRNA levels in the endothelium of the proximal and in-collar sections of six different carotid arteries were determined using real-time RT-PCR (Figure 4, C and D)
. In all cases, high LKLF expression was observed inside the collared region. In one carotid artery of each wild-type and ApoE/ group, LKLF was detectable proximal to the collar but expressed at a more than fourfold lower level than inside the collar. In four carotid arteries the LKLF mRNA was not even detectable in the endothelium proximal to the collar, even though the validity of the experimental procedure and endothelial RNA integrity of these samples was established by results for the endothelial-specific marker CD31 (PECAM-1) and GAPDH. (Figure 4D)
. Thus, based on a comparison of the number of PCR cycles that fails to detect KLF2 in these samples to those enabling detection in the high-shear area we can estimate a 5- to 30-fold induction of LKLF in the high-shear region inside the collar as compared to the proximal low-shear area.
|
|
Dissection of the Response of LKLF to Biomechanical Stresses
Having established the induction of endothelial LKLF expression inside the collared regions of the murine carotid arteries, a possible additional effect on LKLF expression of other (biomechanical) forces than shear stress has to be taken into account. This is particularly relevant as by placement of the constrictive collar, the elasticity of the carotid artery can be reduced. The pulsatile pressure-related distension of the vessel wall, generating endothelial cyclic strain, can thus be reduced and be (partially) responsible for the increase in LKLF expression at this site. We therefore determined the response of LKLF to cyclic endothelial cell stretch and steady shear stress in HUVECs to identify the hemodynamic component that primarily drives endothelial LKLF expression. First, as determined by real-time RT-PCR, 5% and 15% cyclic strain caused a transient twofold reduction of LKLF expression compared to static cultures, which returned to baseline levels within 24 hours (Figure 6A)
.
|
5 dyne/cm2 of shear stress, similar to the levels observed in static cultures. At shear stress levels greater than
5 dyne/cm2 a marked 5- to 36-fold increase compared to this basal level is observed (Figure 6B)
15 dyne/cm2. At higher shear levels, steady flow-induced LKLF expression reached a plateau at 15-fold induction, whereas pulsatile flow-increased LKLF levels showed a linear increase to at least 36-fold at 30 dyne/cm2 (Figure 6B)
5 dyne/cm2 the endothelium adjusts its LKLF levels in an almost linear dose-dependent manner in response to flow variations. LKLF Regulates Transcription of Genes Involved in Vascular Tone Control
The direct relation between LKLF expression and shear stress levels make it a candidate transcription factor to be involved in the regulation of vascular tone, which is known to be regulated primarily by shear forces.10
To gain insight into the role of LKLF in flow-controlled endothelial physiology, LKLF was stably overexpressed in HUVECs under static conditions using a lentiviral overexpression system. By driving the viral overexpression of LKLF with the relatively mild PGK promoter, a stable 20 ± 3-fold (n = 5, P < 0.006) induction of the LKLF mRNA could be achieved, as determined by real-time RT-PCR. The lentiviral induction is shown to result in an increase of LKLF protein that was correctly targeted to the endothelial nucleus (Figure 7, A and B)
and is similar to the LKLF increase and nuclear localization that is observed under prolonged shear stress (Figure 7, C and D)
. Seven days after transduction of HUVECs with the mock or LKLF lentivirus, real-time RT-PCR was used to study the expression of the following known shear-regulated genes: endothelin-1,12
adrenomedullin,14
ACE,13
and eNOS.11
The results reveal consistent transcriptional regulation of these genes by prolonged expression of LKLF in the absence of flow (n = 5) (Figure 7E)
. In parallel, nontransduced HUVEC cultures were exposed to prolonged flow for 7 days and real-time RT-PCR was performed to verify their published flow response (n = 3). The results show similar levels of transcriptional induction/repression as those observed after lentivirus-mediated overexpression of LKLF in static cells (Figure 7E)
. As control, CD31 levels were shown not to be affected by LKLF, which is in agreement with its consistent expression in both the high-and low-shear regions of the murine collar model (Figure 4D)
.
|
| Discussion |
|---|
|
|
|---|
Our in vitro data demonstrate that due to the nonlinear response of LKLF to shear stress and its high induction only at shear stress levels exceeding
5 dyne/cm2, large differences in LKLF expression can be caused by relatively small increases in endothelial shear stress (Figure 6B)
. This sensitive response of LKLF expression to flow supports our observation that the endothelial expression of LKLF is always high at the geometrically regular sites of the human vascular specimens tested, where laminar flow and high-shear stresses are generally expected (Figure 1)
. Finally, our finding that the response of the in vitro LKLF expression to pulsatile flow is significantly higher compared to steady flow is possibly of importance for its in vivo expression. The larger elastic arteries are primarily exposed to pulsatile flow, thus resulting in high endothelial LKLF expression at the sites where flow is mainly laminar. Particularly in relation to the initiation and progression of atherosclerosis, there is a specific interest in the endothelial dysfunctioning that is caused by locally decreased levels of atheroprotective shear stress. A strong correlation between disturbed blood flow and the highly focal process of atherogenesis has been firmly established throughout the recent decades.1-3
Interestingly, in several iliac arteries we observed a correlation between substantially decreased LKLF levels with a substantial, SMC-rich neointima. In this respect, the down-regulation of endothelial LKLF expression by the inflammatory cytokine tumor necrosis factor-
we have previously reported,6
might work together with a flow turbulence-related decrease in endothelial shear stress to focally repress LKLF expression. Thus, a causal relation between decreased LKLF expression and atherosclerosis, as well as other pathologies involving endothelial dysfunction, might be envisioned.
The immediate early response of LKLF expression levels to flow6 implies that this transcription factor is one of the direct functional effects of shear stress on endothelial function, rather than an indirect consequence thereof. The endothelium responds to changes in its biological/biomechanical environment by adapting its gene expression pattern accordingly.2 These changes in gene expression result from modulation of either the production or the activity of transcription factors.32-34 By stably overexpressing LKLF in cultured endothelial cells we now show that a distinct group of known shear-stress regulated genes involved in controlling vascular tone, ACE, EDN, ADM, and NOS3, can be transcriptionally regulated by LKLF. Furthermore, knockdown of LKLF using RNA interference revealed that the response of these genes to flow is primarily dependent on LKLF, with the exception of ACE. The transcriptional response of ACE to flow was recently demonstrated to be dependent on a combination of the Barbie and GAGA response element in the promoter of rat ACE.35 To date, these response elements have not been described as functional LKLF response elements or as working together with Krüppel-like transcription factors to regulate gene transcription. Thus, the apparently independent regulation of ACE by flow and LKLF overexpression therefore suggests that inactivation of LKLF under flow is not sufficient to abolish the flow response of ACE. The dependency of the flow response of endothelin-1, adrenomedullin, and eNOS on LKLF does not exclude the possibility that LKLF is an indirect transcriptional regulator of these genes and a further detailed dissection of the resultant gene network is required. However, long-term expression of LKLF, which would also occur under sustained flow in vivo, is the most physiologically relevant situation that reflects the equilibrium gene expression repertoire of a completely flow-adapted endothelial cell layer. Based on the direct involvement of LKLF in the flow response of the studied vascular tone-related genes, LKLF is expected to function as a positive transcriptional regulator of shear-dependent endothelial function, in particular vasodilation by decreasing the expression of the potent vasoconstrictor endothelin-1 and by simultaneously inducing the expression of vasodilating eNOS. The product of eNOS, nitric oxide, is a strong vasodilator and its decreased bioavailability is closely associated with endothelial dysfunction.11,36 In agreement with our findings, increased eNOS protein has previously been reported in the endothelium of the collared high-shear segments of the murine carotid artery collar model that was used in this study, thus correlating increased eNOS with increased LKLF expression in vivo.19 In addition, LKLF and eNOS expression are positively correlated with calculated high-shear levels in the developing embryonic chicken heart and negatively correlated with endothelin-1 expression,37 which we show here to be transcriptionally repressed by LKLF. Finally, direct proof for transcriptional induction of functional eNOS by LKLF at the promoter level was recently demonstrated in vitro.9
In conclusion, high levels of endothelial LKLF expression, which are consistently observed in vivo, can be achieved by laminar flow. The ability of LKLF to regulate the expression of several prime genes that control endothelial vasomotor function and to modulate proinflammatory endothelial gene expression,9 suggests an important role for LKLF in relaying the healthy, anti-atherosclerotic effects of sustained pulsatile flow to the endothelium at the transcriptional level. Unraveling the pathway that leads to the induction of LKLF would supply novel leads for therapeutically targeting the endothelium to induce a vasodilating and anti-inflammatory phenotype in vascular disease.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by The Netherlands Heart Foundation, The Hague (project grant NHS2000.144 and molecular cardiology program grant M93.007); NWO-Genomics, The Hague (grant 050-10-014); Senter, The Hague (by IOP-genomics grant IGE03012C); and by the European Union (European Vascular Genomics Network grant LSHM-CT-2003-503254).
Accepted for publication May 2, 2005.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Rohlena, O. L. Volger, J. D. van Buul, L. H.P. Hekking, J. M. van Gils, P. I. Bonta, R. D. Fontijn, J. A. Post, P. L. Hordijk, and A. J.G. Horrevoets Endothelial CD81 is a marker of early human atherosclerotic plaques and facilitates monocyte adhesion Cardiovasc Res, October 1, 2008; (2008) cvn256v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Fledderus, R. A. Boon, O. L. Volger, H. Hurttila, S. Yla-Herttuala, H. Pannekoek, A.-L. Levonen, and A. J.G. Horrevoets KLF2 Primes the Antioxidant Transcription Factor Nrf2 for Activation in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1339 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Matouk and P. A. Marsden Epigenetic Regulation of Vascular Endothelial Gene Expression Circ. Res., April 25, 2008; 102(8): 873 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Tuomisto, H. Lumivuori, E. Kansanen, S.-K. Hakkinen, M. P. Turunen, J. V. van Thienen, A. J. Horrevoets, A.-L. Levonen, and S. Yla-Herttuala Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2 Cardiovasc Res, April 1, 2008; 78(1): 175 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Berk Atheroprotective Signaling Mechanisms Activated by Steady Laminar Flow in Endothelial Cells Circulation, February 26, 2008; 117(8): 1082 - 1089. [Full Text] [PDF] |
||||
![]() |
B. C. W. Groenendijk, K. Van der Heiden, B. P. Hierck, and R. E. Poelmann The Role of Shear Stress on ET-1, KLF2, and NOS-3 Expression in the Developing Cardiovascular System of Chicken Embryos in a Venous Ligation Model Physiology, December 1, 2007; 22(6): 380 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Hastings, M. B. Simmers, O. G. McDonald, B. R. Wamhoff, and B. R. Blackman Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1824 - C1833. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Won, S.-N. Zhu, M. Chen, A.-M. Teichert, J. E. Fish, C. C. Matouk, M. Bonert, M. Ojha, P. A. Marsden, and M. I. Cybulsky Relative Reduction of Endothelial Nitric-Oxide Synthase Expression and Transcription in Atherosclerosis-Prone Regions of the Mouse Aorta and in an in Vitro Model of Disturbed Flow Am. J. Pathol., November 1, 2007; 171(5): 1691 - 1704. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Lucitti, E. A. V. Jones, C. Huang, J. Chen, S. E. Fraser, and M. E. Dickinson Vascular remodeling of the mouse yolk sac requires hemodynamic force Development, September 15, 2007; 134(18): 3317 - 3326. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Atkins and M. K. Jain Role of Kruppel-Like Transcription Factors in Endothelial Biology Circ. Res., June 22, 2007; 100(12): 1686 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ghorishi, J. M. Milstein, F. R. Poulain, A. Moon-Grady, T. Tacy, S. H. Bennett, J. R. Fineman, and M. W. Eldridge Shear stress paradigm for perinatal fractal arterial network remodeling in lambs with pulmonary hypertension and increased pulmonary blood flow Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3006 - H3018. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Fledderus, J. V. van Thienen, R. A. Boon, R. J. Dekker, J. Rohlena, O. L. Volger, A.-P. J. J. Bijnens, M. J. A. P. Daemen, J. Kuiper, T. J. C. van Berkel, et al. Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2 Blood, May 15, 2007; 109(10): 4249 - 4257. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bot, S. C.A. de Jager, A. Zernecke, K. A. Lindstedt, T. J.C. van Berkel, C. Weber, and E. A.L. Biessen Perivascular Mast Cells Promote Atherogenesis and Induce Plaque Destabilization in Apolipoprotein E-Deficient Mice Circulation, May 15, 2007; 115(19): 2516 - 2525. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. McMillan, S. N. McMillan, E. Glover, and C. A. Bradfield 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Premature Activation of the KLF2 Regulon during Thymocyte Development J. Biol. Chem., April 27, 2007; 282(17): 12590 - 12597. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Jackson, M. R. Bennett, E. A.L. Biessen, J. L. Johnson, and R. Krams Assessment of Unstable Atherosclerosis in Mice |